These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32487886)

  • 101. Outcomes of Pessary Use at 1 Year in Women Treated for Pelvic Organ Prolapse in a Large Multicenter Registry: Developed by the Pelvic Floor Disorders Registry.
    Yurteri-Kaplan LA; Meyn L; Moalli PA; Bradley CS; Foster RT; Andy UU; Guaderrama N; Gutman RE; Anger JT; Hull A; Propst K; Shippey SS; Brown HW
    Urogynecology (Phila); 2022 Dec; 28(12):800-810. PubMed ID: 36409637
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Changes of intravaginal microbiota and inflammation after self-replacement ring pessary therapy compared to continuous ring pessary usage for pelvic organ prolapse.
    Yoshimura K; Morotomi N; Fukuda K; Kubo T; Taniguchi H
    J Obstet Gynaecol Res; 2020 Jun; 46(6):931-938. PubMed ID: 32189434
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Symptoms, quality of life, and factors affecting women's treatment decisions regarding pelvic organ prolapse.
    Chan SS; Cheung RY; Yiu KW; Lee LL; Pang AW; Chung TK
    Int Urogynecol J; 2012 Aug; 23(8):1027-33. PubMed ID: 22398825
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The impact of pessary use on bowel symptoms: one-year outcomes.
    Brazell HD; Patel M; O'Sullivan DM; Mellen C; LaSala CA
    Female Pelvic Med Reconstr Surg; 2014; 20(2):95-8. PubMed ID: 24566213
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Management of incarcerated vaginal pessaries.
    Poma PA
    J Am Geriatr Soc; 1981 Jul; 29(7):325-7. PubMed ID: 7240622
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Defecatory dysfunction and other clinical variables are predictors of pessary discontinuation.
    Dengler EG; Mounsey LA; Gines F; Agha M; Long T; Geller EJ
    Int Urogynecol J; 2019 Jul; 30(7):1111-1116. PubMed ID: 30343377
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Depressive symptoms affect outcomes of pessary use in postmenopausal women with uterine prolapse.
    Ai FF; Zhu L; Mao M; Zhang Y; Kang J
    Climacteric; 2018 Apr; 21(2):184-188. PubMed ID: 29397780
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The history and usage of the vaginal pessary: a review.
    Oliver R; Thakar R; Sultan AH
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):125-30. PubMed ID: 21255901
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Effect of generalized anxiety disorders on the success of pessary treatment for pelvic organ prolapse.
    Ai FF; Mao M; Zhang Y; Kang J; Zhu L
    Int Urogynecol J; 2018 Aug; 29(8):1147-1153. PubMed ID: 29478112
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Pelvic floor muscle training versus watchful waiting or pessary treatment for pelvic organ prolapse (POPPS): design and participant baseline characteristics of two parallel pragmatic randomized controlled trials in primary care.
    Wiegersma M; Panman CM; Kollen BJ; Vermeulen KM; Schram AJ; Messelink EJ; Berger MY; Lisman-Van Leeuwen Y; Dekker JH
    Maturitas; 2014 Feb; 77(2):168-73. PubMed ID: 24268876
    [TBL] [Abstract][Full Text] [Related]  

  • 111. ESTROgen use for complications in women treating pelvic organ prolapse with vaginal PESSaries (ESTRO-PESS)-a randomized clinical trial.
    de Albuquerque Coelho SC; Giraldo PC; Brito LGO; Juliato CRT
    Int Urogynecol J; 2021 Jun; 32(6):1571-1578. PubMed ID: 33501563
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Where to for pelvic organ prolapse treatment after the FDA pronouncements? A systematic review of the recent literature.
    van Geelen JM; Dwyer PL
    Int Urogynecol J; 2013 May; 24(5):707-18. PubMed ID: 23306770
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Effect of vaginal estrogen on pessary use.
    Dessie SG; Armstrong K; Modest AM; Hacker MR; Hota LS
    Int Urogynecol J; 2016 Sep; 27(9):1423-9. PubMed ID: 26992727
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse.
    Gilchrist AS; Campbell W; Steele H; Brazell H; Foote J; Swift S
    Neurourol Urodyn; 2013 Apr; 32(4):383-6. PubMed ID: 22907839
    [TBL] [Abstract][Full Text] [Related]  

  • 115. [Patient satisfaction and symptom changes in women using a pessary for pelvic organ prolapse].
    Martin Lasnel M; Mourgues J; Fauvet R; Renouf S; Villot A; Pizzoferrato AC
    Prog Urol; 2020 Jun; 30(7):381-389. PubMed ID: 32312625
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Is it safe and effective to maintain the vaginal pessary without removing it for 2 consecutive years?
    Miceli A; Fernández-Sánchez M; Polo-Padillo J; Dueñas-Díez JL
    Int Urogynecol J; 2020 Dec; 31(12):2521-2528. PubMed ID: 32062679
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Factors affecting patient choice for continued observation versus intervention for pelvic organ prolapse.
    Mbaye M; Autumn Edenfield L; Woll A; Swift SE
    Int Urogynecol J; 2021 Feb; 32(2):273-278. PubMed ID: 32725366
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Translabial ultrasound indices of failed pessary fittings in women with symptomatic pelvic organ prolapse.
    Xu H; Wu W; Wang X; Xia Z
    Menopause; 2022 Jan; 29(4):390-396. PubMed ID: 35357363
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Theoretical and practical development of the TOPSY self-management intervention for women who use a vaginal pessary for pelvic organ prolapse.
    Dwyer L; Bugge C; Hagen S; Goodman K; Agur W; Dembinsky M; Graham M; Guerrero K; Hemming C; Khunda A; McClurg D; Melone L; Thakar R; Kearney R;
    Trials; 2022 Sep; 23(1):742. PubMed ID: 36064727
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Location and motion of vaginal pessaries in situ in women with successful and unsuccessful pessary treatment for pelvic organ prolapse.
    Boogaard LL; Triepels CPR; Verhamme LM; van Kuijk SMJ; Donners JJAE; Kluivers KB; Maal TJJ; Weemhoff M; Notten KJB
    Int Urogynecol J; 2023 Sep; 34(9):2293-2300. PubMed ID: 37119269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.